Antiviral therapy in the palliative setting of HCC (BCLC B and C)

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-acting Antiviral Agents

(2020) Manuel Mendizabal et al.   Clinical Gastroenterology and Hepatology

Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C (HCV) infection receiving direct acting antiviral therapy‐ results from the German Hepatitis C‐Registry (DHC‐R)

(2020) Viola Knop et al.   JOURNAL OF VIRAL HEPATITIS

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

(2020) Elizabeth C. Verna et al.   JOURNAL OF HEPATOLOGY

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

(2020) Richard S. Finn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Compensated Cirrhosis and 20 mm Hg

(2020) Enric Reverter et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension

(2020) Sabela Lens et al.   JOURNAL OF HEPATOLOGY

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

(2020) Giuseppe Cabibbo et al.   Cancers

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Andrew X Zhu et al.   LANCET ONCOLOGY

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

(2019) Fabrice Carrat et al.   LANCET

Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

(2019) Giuseppe Cabibbo et al.   JOURNAL OF HEPATOLOGY

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents

(2019) Marco Sanduzzi-Zamparelli et al.   Viruses-Basel

Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN ‐free therapy

(2019) Mattias Mandorfer et al.   HEPATOLOGY

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West

(2019) Hansen Dang et al.   HEPATOLOGY

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

(2019) Chen-Ta Chi et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

(2018) Ezequiel Mauro et al.   HEPATOLOGY

Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

(2018) Luca Saverio Belli et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

(2018) Masatoshi Kudo et al.   LANCET

Hepatocellular carcinoma

(2018) Alejandro Forner et al.   LANCET

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

(2018) Ivan Gentile et al.   Hepatology International

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis

(2017) Sabela Lens et al.   GASTROENTEROLOGY

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

(2017) Pierre Nahon et al.   GASTROENTEROLOGY

Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation

(2017) Juan Manuel Pascasio et al.   JOURNAL OF HEPATOLOGY

Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma

(2017) Lauren A. Beste et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals

(2017) Stacey B. Prenner et al.   JOURNAL OF HEPATOLOGY

A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma

(2017) Giuseppe Cabibbo et al.   LIVER INTERNATIONAL

Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment

(2017) Karin Kozbial et al.   LIVER INTERNATIONAL

Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?

(2017) Loreto Boix et al.   SEMINARS IN LIVER DISEASE

Reply to “Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing”

(2016) Maria Reig et al.   JOURNAL OF HEPATOLOGY

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

(2016) Fabio Conti et al.   JOURNAL OF HEPATOLOGY

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

(2016) Luca Saverio Belli et al.   JOURNAL OF HEPATOLOGY

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

(2016) Mattias Mandorfer et al.   JOURNAL OF HEPATOLOGY

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

(2016) Calogero Cammà et al.   JOURNAL OF HEPATOLOGY

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

(2016) María Reig et al.   JOURNAL OF HEPATOLOGY

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

(2016) Graham R. Foster et al.   JOURNAL OF HEPATOLOGY

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index

(2016) Jacqueline A. Bachofner et al.   LIVER INTERNATIONAL

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

(2015) Massimo Iavarone et al.   HEPATOLOGY

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

(2015) Michael P. Curry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design

(2013) Maria Reig et al.   HEPATOLOGY

The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

(2013) Wolfgang Sieghart et al.   HEPATOLOGY

Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques

(2011) Jordi Bruix et al.   HEPATOLOGY

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute